Phase II Trials for Drug Licensing: Analysis Shows That Efficacy Is Often Overestimated
Phase II drug trials systematically overestimate the efficacy of therapeutics, so that subsequent phase III trials often produce disappointing results.
Read MoreSearch Results for: covid-19
FDA Letter to Healthcare Providers: Use of Serological Tests for Covid-19
FDA recommends the continued use of antibody tests to help identify people who may have been exposed to the SARS-CoV-2 virus or may have recovered from the covid-19 infection.
Read MoreMologic Launches Lab-Based Covid-19 Antibody Tests
The laboratory-based ELISA for covid-19 is expected to produce up to 46,000 results per day.
Read More
Long-Term Care Needs More Testing to Protect Residents and Save Lives
It is time to rally around nursing home and assisted-living residents the same way we have around hospital patients and workers.
Read More
Machine Learning Model Predicts Covid-19 Impact in Smaller Cities
Adapted to smaller populations, the model shows how the covid-19 pandemic peaks under differing social distancing levels.
Read More